Growth advantage for BQ.1.1 Archives - Coronaheadsup.com

Growth advantage for BQ.1.1 is above 100% per week

The Omicron variant BQ.1.1 appears to be in a prime position to drive the coming winter wave in Europe.… ...More...

October 3, 2022October 16, 2022 Coronaheadsup.com BA.2.75.2, Bebtelovimab, BQ.1.1, Convergent, Coronavirus, Europe, Evolution, Evusheld, Genome, Health, Infection, Mutation, Predictions, Research, Testing, Transmission, Treatment, Vaccine, XBB